Andrew's practice focuses on corporate finance, mergers and acquisitions, regulatory compliance and cannabis law.
Andrew's corporate finance experience includes advising issuers, investment dealers and institutional investors in a wide range of financing transactions, including initial public offerings, secondary offerings and public and private offerings of debt and equity securities, both domestically and cross-border, with an emphasis on the cannabis sector and other emerging markets.
In his M&A practice, Andrew advises both acquirers and target companies involved in takeover bids, plans of arrangement, reverse takeovers and other business combinations and corporate transactions.
Andrew has acted on several leading transactions in the cannabis sector and has experience advising on complex commercial arrangements for participants in the cannabis sector, including licencing, royalty and streaming, supply and consulting agreements.
Within BLG, Andrew is the Regional Group Leader of the Securities and Capital Markets practice group and is also the Chair of BLG's National Cannabis Focus Group.